GELWEAVE
LIVE

Serial Number

79144456

Owner

Vascutek Limited

Attorney

Megan E. Fink

Filing Date

Jan 17, 2014

Add to watchlist:

No watchlists yet
View on USPTO

GELWEAVE Trademark

Serial Number: 79144456 • Registration: 4705768

GELWEAVE is a trademark filed by Vascutek Limited on January 17, 2014. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Vascutek Limited

Newmains Avenue
Renfrewshire PA4 9RR , GB

Entity Type: 11

Trademark Details

Filing Date

January 17, 2014

Registration Date

March 24, 2015

Published for Opposition

January 6, 2015

Goods & Services

Surgical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments for treating cardiovascular disease; prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; [ suture materials; ] patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, [ cardiac valves for surgical prostheses, ] stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; [ cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; ] cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2026 COAR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 9, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 2, 2025 APRE
TEAS SECTION 71 RECEIVED
Feb 6, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 24, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 22, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Mar 22, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Mar 22, 2021 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 22, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 18, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 24, 2020 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 4, 2016 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 27, 2015 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 15, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 30, 2015 FICS
FINAL DISPOSITION PROCESSED
Jul 30, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2015 FICR
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 27, 2015 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 22, 2015 APRE
TEAS SECTION 7 REQUEST RECEIVED
Apr 8, 2015 ES7R
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2015 R.PR
POST PUBLICATION AMENDMENT – NOT ENTERED
Mar 7, 2015 CHPN
ASSIGNED TO PETITION STAFF
Mar 6, 2015 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 19, 2015 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jan 3, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 17, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 17, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 4, 2014 PREV
ASSIGNED TO LIE
Nov 25, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2014 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2014 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2014 TROA
REFUSAL PROCESSED BY IB
May 23, 2014 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 30, 2014 RFCR
NON-FINAL ACTION WRITTEN
Apr 29, 2014 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 1, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2014 REPR